Conduit Pharmaceuticals Stock Analysis
| CDTTW Stock | 0.01 0 31.72% |
Conduit Pharmaceuticals is overvalued with Real Value of 0.009504 and Hype Value of 0.01. The main objective of Conduit Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Conduit Pharmaceuticals is worth, separate from its market price. There are two main types of Conduit Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Conduit Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Conduit Pharmaceuticals is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Conduit Stock trading window is adjusted to America/New York timezone.
Conduit |
Conduit Stock Analysis Notes
The company had not issued any dividends in recent years. For more info on Conduit Pharmaceuticals please contact David Tapolczay at 760 471 8536 or go to https://www.conduitpharma.com.Conduit Pharmaceuticals Investment Alerts
| Conduit Pharmaceuticals is not yet fully synchronised with the market data | |
| Conduit Pharmaceuticals had very high historical volatility over the last 90 days | |
| Conduit Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Conduit Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (535 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Conduit Pharmaceuticals generates negative cash flow from operations | |
| Conduit Pharmaceuticals has a frail financial position based on the latest SEC disclosures |
Conduit Pharmaceuticals Thematic Classifications
In addition to having Conduit Pharmaceuticals stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Pharmaceutical ProductsUSA Equities from Pharmaceutical Products industry as classified by Fama & French |
Conduit Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.07) | (0.07) | |
| Return On Capital Employed | (1.03) | (0.97) | |
| Return On Assets | (0.07) | (0.08) | |
| Return On Equity | 1.17 | 0.61 |
Management Efficiency
The company has return on total asset (ROA) of (3.2202) % which means that it has lost $3.2202 on every $100 spent on assets. This is way below average. Conduit Pharmaceuticals' management efficiency ratios could be used to measure how well Conduit Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.07 in 2024. Return On Capital Employed is likely to climb to -0.97 in 2024. At this time, Conduit Pharmaceuticals' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 1.6 M in 2024, whereas Intangible Assets are likely to drop 4,000 in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.01) | (0.01) | |
| Tangible Book Value Per Share | (0.01) | (0.01) | |
| Enterprise Value Over EBITDA | (930.52) | (977.05) | |
| Price Book Value Ratio | (666.81) | (633.47) | |
| Enterprise Value Multiple | (930.52) | (977.05) | |
| Price Fair Value | (666.81) | (633.47) | |
| Enterprise Value | 301.5 M | 192.1 M |
Understanding the operational decisions made by Conduit Pharmaceuticals management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Beta 2.118 | Return On Assets (3.22) |
Conduit Pharmaceuticals Predictive Daily Indicators
Conduit Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Conduit Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.68 | |||
| Day Median Price | 0.0099 | |||
| Day Typical Price | 0.0099 | |||
| Price Action Indicator | (0) | |||
| Period Momentum Indicator | (0) | |||
| Relative Strength Index | 40.85 |
About Conduit Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Conduit Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Conduit shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Conduit Pharmaceuticals. By using and applying Conduit Stock analysis, traders can create a robust methodology for identifying Conduit entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Conduit Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Additional Tools for Conduit Stock Analysis
When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.